BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND CCNE1, CCNE, 898, ENSG00000105173, P24864 AND Treatment
21 results:

  • 1. Deep learning for [
    Häggström I; Leithner D; Alvén J; Campanella G; Abusamra M; Zhang H; Chhabra S; Beer L; Haug A; Salles G; Raderer M; Staber PB; Becker A; Hricak H; Fuchs TJ; Schöder H; Mayerhoefer ME
    Lancet Digit Health; 2024 Feb; 6(2):e114-e125. PubMed ID: 38135556
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Deep convolutional neural network for differentiating between sarcoidosis and lymphoma based on [
    Aoki H; Miyazaki Y; Anzai T; Yokoyama K; Tsuchiya J; Shirai T; Shibata S; Sakakibara R; Mitsumura T; Honda T; Furusawa H; Okamoto T; Tateishi T; Tamaoka M; Yamamoto M; Takahashi K; Tateishi U; Yamaguchi T
    Eur Radiol; 2024 Jan; 34(1):374-383. PubMed ID: 37535157
    [TBL] [Abstract] [Full Text] [Related]  

  • 3.
    Cui Y; Jiang Y; Deng X; Long W; Liu B; Fan W; Li Y; Zhang X
    Acad Radiol; 2023 Jul; 30(7):1408-1418. PubMed ID: 36437191
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single-arm study.
    Shadman M; Flinn IW; Levy MY; Porter RF; Burke JM; Zafar SF; Misleh J; Kingsley EC; Yimer HA; Freeman B; Rao SS; Chaudhry A; Tumula PK; Gandhi MD; Manda S; Chen DY; By K; Xu L; Liu Y; Crescenzo R; Idoine A; Zhang X; Cohen A; Huang J; Sharman JP
    Lancet Haematol; 2023 Jan; 10(1):e35-e45. PubMed ID: 36400069
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Diffuse Large B-Cell Epstein-Barr Virus-Positive Primary CNS lymphoma in Non-AIDS Patients: High Diagnostic Accuracy of DSC Perfusion Metrics.
    Pons-Escoda A; García-Ruíz A; Naval-Baudin P; Grussu F; Viveros M; Vidal N; Bruna J; Plans G; Cos M; Perez-Lopez R; Majós C
    AJNR Am J Neuroradiol; 2022 Nov; 43(11):1567-1574. PubMed ID: 36202547
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Patients with treated indolent lymphomas immunized with BNT162b2 have reduced anti-spike neutralizing IgG to SARS-CoV-2 variants, but preserved antigen-specific T cell responses.
    Beaton B; Sasson SC; Rankin K; Raedemaeker J; Wong A; Hastak P; Phetsouphanh C; Warden A; Klemm V; Munier CML; Hoppe AC; Tea F; Pillay A; Stella AO; Aggarwal A; Lavee O; Caterson ID; Turville S; Kelleher AD; Brilot F; Trotman J
    Am J Hematol; 2023 Jan; 98(1):131-139. PubMed ID: 35607995
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Trends in Prices of Drugs Used to Treat Metastatic Non-Small Cell Lung Cancer in the US From 2015 to 2020.
    Desai A; Scheckel C; Jensen CJ; Orme J; Williams C; Shah N; Leventakos K; Adjei AA
    JAMA Netw Open; 2022 Jan; 5(1):e2144923. PubMed ID: 35076701
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Obstetric and maternal outcomes in patients diagnosed with Hodgkin lymphoma during pregnancy: a multicentre, retrospective, cohort study.
    Maggen C; Dierickx D; Lugtenburg P; Laenen A; Cardonick E; Shmakov RG; Bellido M; Cabrera-Garcia A; Gziri MM; Halaska MJ; Ottevanger PB; Van Calsteren K; O'Laughlin A; Polushkina E; Van Dam L; Avivi I; Vandenberghe P; Woei-A-Jin FJSH; Amant F;
    Lancet Haematol; 2019 Nov; 6(11):e551-e561. PubMed ID: 31564649
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The repertoire of genetic alterations in salivary duct carcinoma including a novel HNRNPH3-ALK rearrangement.
    Dogan S; Ng CKY; Xu B; Kumar R; Wang L; Edelweiss M; Scott SN; Zehir A; Drilon A; Morris LGT; Lee NY; Antonescu CR; Ho AL; Katabi N; Berger MF; Reis-Filho JS
    Hum Pathol; 2019 Jun; 88():66-77. PubMed ID: 30946933
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. miR-497 suppresses cycle progression through an axis involving CDK6 in ALK-positive cells.
    Hoareau-Aveilla C; Quelen C; Congras A; Caillet N; Labourdette D; Dozier C; Brousset P; Lamant L; Meggetto F
    Haematologica; 2019 Feb; 104(2):347-359. PubMed ID: 30262555
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Efficacy and safety of adalimumab in the treatment of Crohn´s disease in children.
    Navas-López VM; Blasco-Alonso J; Girón-Fernández-Crehuet F; Serrano-Nieto MJ; Sierra-Salinas C
    Rev Esp Enferm Dig; 2013; 105(10):579-84. PubMed ID: 24641454
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. qPET - a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphoma.
    Hasenclever D; Kurch L; Mauz-Körholz C; Elsner A; Georgi T; Wallace H; Landman-Parker J; Moryl-Bujakowska A; Cepelová M; Karlén J; Álvarez Fernández-Teijeiro A; Attarbaschi A; Fosså A; Pears J; Hraskova A; Bergsträsser E; Beishuizen A; Uyttebroeck A; Schomerus E; Sabri O; Körholz D; Kluge R
    Eur J Nucl Med Mol Imaging; 2014 Jul; 41(7):1301-8. PubMed ID: 24604592
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Marital status and survival in patients with cancer.
    Aizer AA; Chen MH; McCarthy EP; Mendu ML; Koo S; Wilhite TJ; Graham PL; Choueiri TK; Hoffman KE; Martin NE; Hu JC; Nguyen PL
    J Clin Oncol; 2013 Nov; 31(31):3869-76. PubMed ID: 24062405
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prevalence of being underweight and overweight and obesity at diagnosis in UK patients with childhood acute lymphoblastic leukaemia 1985-2002.
    Aldhafiri FK; McColl JH; Reilly JJ
    J Hum Nutr Diet; 2014 Feb; 27(1):76-9. PubMed ID: 23781853
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial.
    Vora A; Goulden N; Wade R; Mitchell C; Hancock J; Hough R; Rowntree C; Richards S
    Lancet Oncol; 2013 Mar; 14(3):199-209. PubMed ID: 23395119
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Parenthood in survivors of Hodgkin lymphoma: an EORTC-GELA general population case-control study.
    van der Kaaij MA; Heutte N; Meijnders P; Abeilard-Lemoisson E; Spina M; Moser LC; Allgeier A; Meulemans B; Dubois B; Simons AH; Lugtenburg PJ; Aleman BM; Noordijk EM; Fermé C; Thomas J; Stamatoullas A; Fruchart C; Brice P; Gaillard I; Doorduijn JK; Sebban C; Smit WG; Bologna S; Roesink JM; Ong F; André MP; Raemaekers JM; Henry-Amar M; Kluin-Nelemans HC
    J Clin Oncol; 2012 Nov; 30(31):3854-63. PubMed ID: 23008303
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Gene networks involved in apoptosis induced by hyperthermia in human lymphoma U937 cells.
    Furusawa Y; Tabuchi Y; Takasaki I; Wada S; Ohtsuka K; Kondo T
    Cell Biol Int; 2009 Dec; 33(12):1253-62. PubMed ID: 19732844
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Diffuse large B-cell lymphoma with overexpression of cyclin e substantiates poor standard treatment response and inferior outcome.
    Tzankov A; Gschwendtner A; Augustin F; Fiegl M; Obermann EC; Dirnhofer S; Went P
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2125-32. PubMed ID: 16609025
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Internal microdosimetry for single cells in radioimmunotherapy of B-cell lymphoma.
    Hindorf C; Emfietzoglou D; Lindén O; Kostarelos K; Strand SE
    Cancer Biother Radiopharm; 2005 Apr; 20(2):224-30. PubMed ID: 15869460
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [A tal-1 deletion as real-time quantitative polymerase chain reaction target for detection of minimal residual disease in T-lineage acute lymphoblastic leukemia].
    Wang L; Zhang LP; Li ZG; Cheng YF; Tian KG; Lu AD
    Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):170-3. PubMed ID: 15833185
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.